R1 RCM (NASDAQ:RCM) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

Several other research firms also recently commented on RCM. Robert W. Baird restated a “hold” rating and set a $5.00 price objective on shares of R1 RCM in a report on Tuesday, September 26th. Zacks Investment Research upgraded R1 RCM from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 4th.

R1 RCM (NASDAQ:RCM) opened at $4.27 on Friday. R1 RCM has a 12 month low of $2.02 and a 12 month high of $4.64. The stock has a market capitalization of $458.85, a P/E ratio of -16.42 and a beta of -0.48.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings results on Tuesday, October 31st. The financial services provider reported ($0.08) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.05). R1 RCM had a negative net margin of 1.32% and a negative return on equity of 9.33%. equities research analysts anticipate that R1 RCM will post -0.12 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. bought a new stake in R1 RCM during the second quarter worth $1,194,000. Vanguard Group Inc. bought a new stake in R1 RCM during the second quarter worth $10,550,000. P.A.W. Capital Corp grew its holdings in R1 RCM by 109.2% during the third quarter. P.A.W. Capital Corp now owns 535,000 shares of the financial services provider’s stock worth $1,985,000 after buying an additional 279,300 shares in the last quarter. Paradigm Capital Management Inc. NY grew its holdings in R1 RCM by 14.8% during the third quarter. Paradigm Capital Management Inc. NY now owns 6,967,900 shares of the financial services provider’s stock worth $25,851,000 after buying an additional 900,753 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in R1 RCM during the second quarter worth $1,051,000. Hedge funds and other institutional investors own 47.41% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://theolympiareport.com/2018/01/19/r1-rcm-rcm-stock-rating-lowered-by-bidaskclub.html.

R1 RCM Company Profile

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.